A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPD (Q63338768)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPD |
clinical trial |
Statements
DB2113361 (English)
0 references
A 24-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GSK573719/GW642444 Inhalation Powder and the Individual Components Delivered Once-Daily Via a Novel Dry Powder Inhaler in Subjects With Chronic Obstructive Pulmonary Disease (English)
0 references
1 March 2011
0 references
1 March 2012
0 references
1,493
0 references
40 year
0 references